These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 23410788

  • 1. Curcumin aggravates CNS pathology in experimental systemic lupus erythematosus.
    Foxley S, Zamora M, Hack B, Alexander RR, Roman B, Quigg RJ, Alexander JJ.
    Brain Res; 2013 Apr 04; 1504():85-96. PubMed ID: 23410788
    [Abstract] [Full Text] [Related]

  • 2. Absence of functional alternative complement pathway alleviates lupus cerebritis.
    Alexander JJ, Jacob A, Vezina P, Sekine H, Gilkeson GS, Quigg RJ.
    Eur J Immunol; 2007 Jun 04; 37(6):1691-701. PubMed ID: 17523212
    [Abstract] [Full Text] [Related]

  • 3. Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis.
    Alexander JJ, Bao L, Jacob A, Kraus DM, Holers VM, Quigg RJ.
    Biochim Biophys Acta; 2003 Nov 20; 1639(3):169-76. PubMed ID: 14636948
    [Abstract] [Full Text] [Related]

  • 4. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J, Rupanagudi KV, Kulkarni OP, Darisipudi MN, Allam R, Anders HJ.
    J Immunol; 2011 Sep 15; 187(6):3413-21. PubMed ID: 21849682
    [Abstract] [Full Text] [Related]

  • 5. Time course and nature of brain atrophy in the MRL mouse model of central nervous system lupus.
    Sled JG, Spring S, van Eede M, Lerch JP, Ullal S, Sakic B.
    Arthritis Rheum; 2009 Jun 15; 60(6):1764-74. PubMed ID: 19479832
    [Abstract] [Full Text] [Related]

  • 6. MRL/lpr mice have alterations in brain metabolism as shown with [1H-13C] NMR spectroscopy.
    Alexander JJ, Zwingmann C, Quigg R.
    Neurochem Int; 2005 Jul 15; 47(1-2):143-51. PubMed ID: 15893408
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Exercise alleviates symptoms of CNS lupus.
    Jacob A, Nina Peralta L, Pegues D, Okamura K, Chang A, McSkimming D, Alexander J.
    Brain Res; 2021 Aug 15; 1765():147478. PubMed ID: 33852888
    [Abstract] [Full Text] [Related]

  • 9. C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice.
    Wenderfer SE, Ke B, Hollmann TJ, Wetsel RA, Lan HY, Braun MC.
    J Am Soc Nephrol; 2005 Dec 15; 16(12):3572-82. PubMed ID: 16207826
    [Abstract] [Full Text] [Related]

  • 10. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, Masuyama J, Fujimura A, Kobayashi E, Kano S, Minota S.
    J Rheumatol; 2002 Apr 15; 29(4):707-16. PubMed ID: 11950011
    [Abstract] [Full Text] [Related]

  • 11. Constitutive knockout of interleukin-6 ameliorates memory deficits and entorhinal astrocytosis in the MRL/lpr mouse model of neuropsychiatric lupus.
    Reynolds J, Huang M, Li Y, Meineck M, Moeckel T, Weinmann-Menke J, Mohan C, Schwarting A, Putterman C.
    J Neuroinflammation; 2024 Apr 10; 21(1):89. PubMed ID: 38600510
    [Abstract] [Full Text] [Related]

  • 12. Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL/lpr mice.
    Hu N, Long H, Zhao M, Yin H, Lu Q.
    Scand J Rheumatol; 2009 Apr 10; 38(6):464-71. PubMed ID: 19922023
    [Abstract] [Full Text] [Related]

  • 13. Fate of immune complexes, glomerulonephritis, and cell-mediated vasculitis in lupus-prone MRL/Mp lpr/lpr mice.
    Cruse JM, Lewis RE, Dilioglou S.
    Exp Mol Pathol; 2000 Dec 10; 69(3):211-22. PubMed ID: 11115362
    [Abstract] [Full Text] [Related]

  • 14. Deposition of chromatin-IgG complexes in skin of nephritic MRL-lpr/lpr mice is associated with increased local matrix metalloprotease activities.
    Hedberg A, Fismen S, Fenton KA, Mortensen ES, Rekvig OP.
    Exp Dermatol; 2010 Aug 10; 19(8):e265-74. PubMed ID: 20500770
    [Abstract] [Full Text] [Related]

  • 15. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G, Maier H, Franz TJ, Escribese M, Chilla S, Segerer S, Camarasa N, Schmid H, Banas B, Kalaydjiev S, Busch DH, Pfeffer K, Mampaso F, Schlöndorff D, Luckow B.
    J Am Soc Nephrol; 2005 Dec 10; 16(12):3592-601. PubMed ID: 16267157
    [Abstract] [Full Text] [Related]

  • 16. Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: effects of disease progression and lipopolyssacharide administration.
    Licht R, van Bruggen MC, Oppers-Walgreen B, Rijke TP, Berden JH.
    Arthritis Rheum; 2001 Jun 10; 44(6):1320-30. PubMed ID: 11407691
    [Abstract] [Full Text] [Related]

  • 17. Significantly reduced lymphadenopathy, salivary gland infiltrates and proteinuria in MRL-lpr/lpr mice treated with ultrasoluble curcumin/turmeric: increased survival with curcumin treatment.
    Kurien BT, Harris VM, Quadri SM, Coutinho-de Souza P, Cavett J, Moyer A, Ittiq B, Metcalf A, Ramji HF, Truong D, Kumar R, Koelsch KA, Centola M, Payne A, Danda D, Scofield RH.
    Lupus Sci Med; 2015 Jun 10; 2(1):e000114. PubMed ID: 26380101
    [Abstract] [Full Text] [Related]

  • 18. Immunosuppression prevents neuronal atrophy in lupus-prone mice: evidence for brain damage induced by autoimmune disease?
    Sakic B, Kolb B, Whishaw IQ, Gorny G, Szechtman H, Denburg JA.
    J Neuroimmunol; 2000 Nov 01; 111(1-2):93-101. PubMed ID: 11063826
    [Abstract] [Full Text] [Related]

  • 19. Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr / lpr mice.
    Nicoletti F, Di Marco R, Zaccone P, Xiang M, Magro G, Grasso S, Morrone S, Santoni A, Shoenfeld Y, Garotta G, Meroni P.
    Eur J Immunol; 2000 Feb 01; 30(2):438-47. PubMed ID: 10671199
    [Abstract] [Full Text] [Related]

  • 20. The potential pathogenetic link between peripheral immune activation and the central innate immune response in neuropsychiatric systemic lupus erythematosus.
    Tomita M, Khan RL, Blehm BH, Santoro TJ.
    Med Hypotheses; 2004 Feb 01; 62(3):325-35. PubMed ID: 14975498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.